Oxytocin acetate → Oxytocin

HRID 1395934Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1395934
[CH3:1][CH2:2][C@@H:3]([C@@H:5]1[NH:29][C:27](=[O:28])[C@H:26]([CH2:30][C:31]2[CH:36]=[CH:35][C:34]([OH:37])=[CH:33][CH:32]=2)[NH:25][C:23](=[O:24])[C@@H:22]([NH2:38])[CH2:21][S:20][S:19][CH2:18][C@@H:17]([C:39]([N:41]2[C@H:45]([C:46]([NH:48][C@H:49]([C:54]([NH:56][CH2:57][C:58]([NH2:60])=[O:59])=[O:55])[CH2:50][CH:51]([CH3:53])[CH3:52])=[O:47])[CH2:44][CH2:43][CH2:42]2)=[O:40])[NH:16][C:14](=[O:15])[C@H:13]([CH2:61][C:62]([NH2:64])=[O:63])[NH:12][C:10](=[O:11])[C@H:9]([CH2:65][CH2:66][C:67]([NH2:69])=[O:68])[NH:8][C:6]1=[O:7])[CH3:4].CC(O)=O>CCOC(C)=O.CO>[CH3:1][CH2:2][C@@H:3]([C@@H:5]1[NH:29][C:27](=[O:28])[C@H:26]([CH2:30][C:31]2[CH:36]=[CH:35][C:34]([OH:37])=[CH:33][CH:32]=2)[NH:25][C:23](=[O:24])[C@@H:22]([NH2:38])[CH2:21][S:20][S:19][CH2:18][C@@H:17]([C:39]([N:41]2[C@H:45]([C:46]([NH:48][C@H:49]([C:54]([NH:56][CH2:57][C:58]([NH2:60])=[O:59])=[O:55])[CH2:50][CH:51]([CH3:53])[CH3:52])=[O:47])[CH2:44][CH2:43][CH2:42]2)=[O:40])[NH:16][C:14](=[O:15])[C@H:13]([CH2:61][C:62]([NH2:64])=[O:63])[NH:12][C:10](=[O:11])[C@H:9]([CH2:65][CH2:66][C:67]([NH2:69])=[O:68])[NH:8][C:6]1=[O:7])[CH3:4]

Komponenten

4

Edukt 1

HCID 12004215Oxytocin acetate

Produkt 1

HCID 439302OxytocinAusbeute 71,5 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 887MethanolLösungsmittelHCID 8857Ethyl AcetateLösungsmittel2×

Versuchsvorschrift

PLGA polymer (MW 13,000, 180 mg) was dissolved in EtOAc (900 μL). Oxytocin acetate (20 mg) was dissolved in MeOH (100 μL) and added to the polymer solution yielding a milky suspension as the organic phase. The resulting organic phase was combined with a 1% PVA aqueous phase containing 5% EtOAc to provide an emulsion. The emulsion was collected directly into a 10 mM sodium phosphate (pH 8, 0° C., 150 mL) solvent extraction solution and stirred for four hours while warming to room temperature to extract EtOAc. Hardened microparticles were collected by filtration, washed with water, air dried and stored at 4° C. This provided formulation BL (143 mg, 71.5% yield) with a median particle size 44.0 μm. The core load (1.67%), encapsulation efficiency (16.7%) and in vitro burst (46.3%) were determined by RP-HPLC assay.

Aufarbeitung

  1. additionadded to the polymer solution
  2. customyielding a milky suspension as the organic phase
  3. customto provide an emulsion
  4. customThe emulsion was collected directly into a 10 mM sodium phosphate (pH 8, 0° C., 150 mL) solvent extraction solution
  5. extractionto extract EtOAc
  6. filtrationHardened microparticles were collected by filtration
  7. washwashed with water, air
  8. customdried
  9. customstored at 4° C

Quellen und Nachweise

ORD-Eintrag
ord-ad58bda64d674ce1aa41b2fa12c6883f
Quelldatensatz
uspto-grants-2014_12
Patentnummer
US08900636B2

Notizen zur Reaktion

Wird geladen…